Related Experiment Video
Updated: Feb 9, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified
Shuobo Boboila1,2,3, Gonzalo Lopez4,5,6, Jiyang Yu4,7
1Department of Pediatrics, Columbia University Medical Center, New York, NY, 10032, USA.
Abstract:
Despite the identification of MYCN amplification as an adverse prognostic marker in neuroblastoma, MYCN inhibitors have yet to be developed. Here, by integrating evidence from a whole-genome shRNA library screen and the computational inference of master regulator proteins, we identify transcription factor activating protein 4 (TFAP4) as a critical effector of MYCN amplification in neuroblastoma, providing a novel synthetic lethal target. We demonstrate that TFAP4 is a direct target of MYCN in neuroblastoma cells, and that its expression and activity strongly negatively correlate with neuroblastoma patient survival. Silencing TFAP4 selectively inhibits MYCN-amplified neuroblastoma cell growth both in vitro and in vivo, in xenograft mouse models. Mechanistically, silencing TFAP4 induces neuroblastoma differentiation, as evidenced by increased neurite outgrowth and upregulation of neuronal markers. Taken together, our results demonstrate that TFAP4 is a key regulator of MYCN-amplified neuroblastoma and may represent a valuable novel therapeutic target.
Insights
Transcription factor activating protein 4 (TFAP4) is a critical effector of MYCN amplification in neuroblastoma. Silencing TFAP4 inhibits neuroblastoma growth and induces differentiation, offering a novel therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYCN amplification is a poor prognostic marker in neuroblastoma.
- Effective MYCN inhibitors are currently lacking for neuroblastoma treatment.
Purpose of the Study:
- To identify novel therapeutic targets for MYCN-amplified neuroblastoma.
- To investigate the role of transcription factor activating protein 4 (TFAP4) in neuroblastoma.
Main Methods:
- Whole-genome shRNA library screen to identify key effectors.
- Computational inference of master regulator proteins.
- In vitro and in vivo studies including xenograft mouse models.
Main Results:
- TFAP4 identified as a critical effector of MYCN amplification.
- TFAP4 is a direct MYCN target, negatively correlating with patient survival.
- TFAP4 silencing selectively inhibits MYCN-amplified neuroblastoma growth and induces differentiation.
Conclusions:
- TFAP4 is a key regulator in MYCN-amplified neuroblastoma.
- TFAP4 represents a promising synthetic lethal target for neuroblastoma therapy.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Cooperative Binding of Transcription Regulators

